Automated insulin delivery systems can potentially modify insulin dosing in response to activity monitors to reduce the risk (or severity) of exercise-induced hypoglycemia in people living with type 1 diabetes [7-10]. The gene discussed is INS; the disease is type 1 diabetes mellitus.